AbbVie - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,153,000 | 5,629,000 | 5,906,000 | 6,532,000 | 7,822,000 | 8,881,000 | 8,721,000 | 9,994,000 |
| Profit before tax | 344,000 | 425,000 | 633,000 | 602,000 | 615,000 | 1,044,000 | 928,000 | 1,048,000 |
| Net profit | 264,000 | 309,000 | 473,000 | 418,000 | 422,000 | 843,000 | 681,000 | 710,000 |
| Equity | 2,614,000 | 2,923,000 | 3,396,000 | 3,281,000 | 3,703,000 | 4,546,000 | 5,227,000 | 5,937,000 |
| Liabilities | 835,000 | 879,000 | 814,000 | 1,152,000 | 1,232,000 | 1,204,000 | 1,429,000 | 1,642,000 |
| Non-current assets | 635,000 | 541,000 | 419,000 | 312,000 | 189,000 | 126,000 | 131,000 | 119,000 |
| Current assets | 2,939,000 | 3,468,000 | 3,928,000 | 4,224,000 | 4,876,000 | 5,728,000 | 6,665,000 | 7,597,000 |
| Total assets | 3,574,000 | 4,009,000 | 4,347,000 | 4,536,000 | 5,065,000 | 5,854,000 | 6,796,000 | 7,716,000 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 909,363 | 969,506 | 1,035,425 |
| Social insurance contributions | - | - | - | - | - | 769,713 | 766,199 | 880,886 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.4% | +9.2% | +4.9% | +10.6% | +19.7% | +13.5% | -1.8% | +14.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.4% | 7.7% | 10.9% | 9.2% | 8.3% | 14.4% | 10.0% | 9.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.1% | 10.6% | 13.9% | 12.7% | 11.4% | 18.5% | 13.0% | 12.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.1% | 5.5% | 8.0% | 6.4% | 5.4% | 9.5% | 7.8% | 7.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.7% | 7.6% | 10.7% | 9.2% | 7.9% | 11.8% | 10.6% | 10.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 225,679 | 231,329 | 246,940 | 215,341 | 221,378 | 230,177 | 227,011 | 238,425 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AbbVie - Social security debts
The company had no debts to Sodra
AbbVie - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AbbVie, UAB (company code 302679058) is a Private Limited Liability Company engaged in market research and public opinion polling. In the latest financial year, 2025, the company generated revenue of €9.99M and net profit of €710.0K, which corresponded to a profit margin of 7.1%. Revenue increased by 14.6% year on year, and the two-year revenue growth was 12.5%. The revenue trend shows a dip from €8.88M in 2023 to €8.72M in 2024, followed by a recovery in 2025. Net profit also declined from €843.0K in 2023 to €681.0K in 2024 before improving to €710.0K in 2025. At year-end 2025, total assets stood at €7.72M, equity at €5.94M and liabilities at €1.64M. The equity ratio was 76.9%, debt to equity 0.28, return on equity 12.0% and return on assets 9.2%. Asset turnover was 1.30x. With revenue of €243.8K per employee and profit of €17.3K per employee, the company showed solid operating productivity.